Cardinal Health Investor Day to Highlight Long-Term Value Creation - Cardinal Health (NYSE:CAH)
Benzinga 2023-06-08 10:54:57 • 17 mins
- Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1
- Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance of $6.45 to $6.70 (15% growth at the mid-points)
- Providing long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS (3-year CAGR)2
- Raising long-term financial target for Pharmaceutical segment profit to 4% to 6% growth, from "low-single digit to mid-single digit" growth
- Updating Medical Improvement Plan timeline for $650M+ in segment profit to FY263
- Board of Directors approved new $3.5B share repurchase authorization expiring December 31, 2027; company plans to execute at least $2.0B of share repurchases over the next three years
- Company provides strategic updates
DUBLIN, Ohio, June 8, 2023 /PRNewswire/ -- Cardinal Health CAH today will host an Investor Day beginning at 9:00 a.m. ET, where among other updates, management will detail its growth strategies to maximize the company's potential for all stakeholders and move healthcare forward.
